Cargando…
Human Platelets Take up Anti-VEGF Agents
PURPOSE: Growing evidence suggests different systemic exposure of anti-vascular endothelial growth factor (anti-VEGF) agents with repeated intravitreal application. Since the penetration of anti-VEGF agents through vascular barrier was reported, the interaction of anti-VEGF with nonresident platelet...
Autores principales: | Sobolewska, B., Fehrenbacher, B., Münzer, P., Kalbacher, H., Geue, S., Stellos, Konstantinos, Schaller, M., Ziemssen, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219439/ https://www.ncbi.nlm.nih.gov/pubmed/34221496 http://dx.doi.org/10.1155/2021/8811672 |
Ejemplares similares
-
pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
por: Sobolewska, Bianka, et al.
Publicado: (2017) -
Correction to: pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
por: Sobolewska, Bianka, et al.
Publicado: (2017) -
Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration
por: Sobolewska, Bianka, et al.
Publicado: (2021) -
Quantifying Conflict of Interest in the Choice of Anti-VEGF Agents
por: Browning, David J, et al.
Publicado: (2021) -
Anti-VEGF and anti-EGFR agents open up new horizons changing the landscape for their associations
por: Milano, Gerard
Publicado: (2016)